NEW THERAPIES VIA NATURAL MOLECULES
Inositec from Zurich is developing novel therapeutics from its proprietary platform of small molecules. The lead product is a novel treatment for a widespread colon infection and the second is an inhibitor of vascular calcifications.
Additional Teammembers
Prof. Bastien Castagner, co-founder; Prof. Jean-Christophe Leroux, co-founder